EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury

Ana I Salazar-Puerta iD, María A Rincon-Benavides iD, Tatiana Z Cuellar-Gaviria iD, Julian Aldana iD, Gabriela Vasquez Martinez iD, Lilibeth Ortega-Pineda iD, Devleena Das, Daniel Dodd iD, Charles A Spencer, Binbin Deng, David W McComb, Joshua A Englert iD und 5 weitere

Advanced Materials · 2023-07 · 35 (28)

DOI: 10.1002/adma.202210579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 05.06.2023. Verfasst von Ana I Salazar-Puerta und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA. Hauptthemen laut MEDLINE: Acute Lung Injury, Respiratory Distress Syndrome, Extracellular Vesicles. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIBIB NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) represents a significant burden to the healthcare system, with ≈200 000 cases diagnosed annually in the USA. ARDS patients suffer from severe refractory hypoxemia, alveolar‐capillary barrier dysfunction, impaired surfactant function, and abnormal upregulation of inflammatory pathways that lead to intensive care unit admission, prolonged hospitalization, and increased disability‐adjusted life years. Currently, there is no cure or FDA‐approved therapy for ARDS. This work describes the implementation of engineered extracellular vesicle (eEV)‐based nanocarriers for targeted nonviral delivery of anti‐inflammatory payloads to the inflamed/injured lung. The results show the ability of surfactant protein A (SPA)‐functionalized IL‐4 ‐ and IL‐10 ‐loaded eEVs to promote intrapulmonary retention and reduce inflammation, both in vitro and in vivo. Significant attenuation is observed in tissue damage, proinflammatory cytokine secretion, macrophage activation, influx of protein‐rich fluid, and neutrophil infiltration into the alveolar space as early as 6 h post‐eEVs treatment. Additionally, metabolomics analyses show that eEV treatment causes significant changes in the metabolic profile of inflamed lungs, driving the secretion of key anti‐inflammatory metabolites. Altogether, these results establish the potential of eEVs derived from dermal fibroblasts to reduce inflammation, tissue damage, and the prevalence/progression of injury during ARDS via nonviral delivery of anti‐inflammatory genes/transcripts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryRespiratory Distress SyndromeExtracellular VesiclesHumansMiceAnimalsDisease Models, AnimalInflammationAnti-Inflammatory AgentsFibroblasts

Stichwörter der Autor:innen

anti-inflammatory extracellular vesiclesengineered extracellular vesicleslung injurynonviral gene deliverynovel nanocarrierspulmonary inflammation

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA.
  • Biophysics Program, The Ohio State University, Columbus, OH, 43210, USA.
  • Biochemistry Program, The Ohio State University, Columbus, OH, 43210, USA.
  • Kidney and Urinary Tract Research Center, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, 43215, USA.
  • Biomedical Science Graduate Program, The Ohio State University, Columbus, OH, 43210, USA.
  • Division of Cardiac Surgery, Department of Surgery, The Ohio State University, Columbus, OH, 43210, USA.

ORCID-Profile: Ana I Salazar-Puerta, María A Rincon-Benavides, Tatiana Z Cuellar-Gaviria, Julian Aldana, Gabriela Vasquez Martinez, Lilibeth Ortega-Pineda, Daniel Dodd, Joshua A Englert, Samir Ghadiali, Loren E Wold, Daniel Gallego-Perez, Natalia Higuita-Castro

Förderung

  • NIH HHS
  • NIBIB NIH HHS
  • NIDDK NIH HHS
  • NIAMS NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Salazar-Puerta, A. I., Rincon-Benavides, M. A., Cuellar-Gaviria, T. Z., Aldana, J., Vasquez Martinez, G., Ortega-Pineda, L., Das, D., Dodd, D., Spencer, C. A., Deng, B., McComb, D. W., Englert, J. A., Ghadiali, S., Zepeda-Orozco, D., Wold, L. E., Gallego-Perez, D., & Higuita-Castro, N. (2023). Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury. Advanced Materials, 35(28). https://doi.org/10.1002/adma.202210579

Vancouver

Salazar-Puerta AI, Rincon-Benavides MA, Cuellar-Gaviria TZ, Aldana J, Vasquez Martinez G, Ortega-Pineda L, et al. Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury. Advanced Materials. 2023;35(28). doi:10.1002/adma.202210579

BibTeX
@article{SalazarPuerta2023,
  author = {Salazar-Puerta, Ana I and Rincon-Benavides, María A and Cuellar-Gaviria, Tatiana Z and Aldana, Julian and Vasquez Martinez, Gabriela and Ortega-Pineda, Lilibeth and Das, Devleena and Dodd, Daniel and Spencer, Charles A and Deng, Binbin and McComb, David W and Englert, Joshua A and Ghadiali, Samir and Zepeda-Orozco, Diana and Wold, Loren E and Gallego-Perez, Daniel and Higuita-Castro, Natalia},
  title = {Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {28},
  doi = {10.1002/adma.202210579}
}
Kostenlos starten →